NCT02399124View on ClinicalTrials.gov

Post Marketing Surveillance for PROSENSE™ a Cryotherapy Treatment of Renal Cell Carcinoma

NAActive, not recruitingINTERVENTIONAL
Enrollment

120

Participants

Timeline

Start Date

July 31, 2014

Primary Completion Date

February 28, 2026

Study Completion Date

February 28, 2026

Conditions
Renal Cell Carcinoma
Interventions
DEVICE

PROSENSE™

single arm, open label, PROSENSE™ treatment

Trial Locations (2)

70300

Shamir Medical Center, Ẕerifin

Unknown

Bnei Zion Medical Center, Haifa

Sponsors

Collaborators (1)

Bnai Zion Medical Center
All Listed Sponsors
collaborator

Bnai Zion Medical Center

OTHER_GOV

collaborator

Assaf-Harofeh Medical Center

OTHER_GOV

lead

IceCure Medical Ltd.

INDUSTRY